Related Experiment Video

Updated: May 7, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
10:27

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

1.5K

Decoding the regulatory roles of circular RNAs in cardiac fibrosis

Qianhui You1, Jiajing Yu1, Runfang Pan1

  • 1Department of Anatomy, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.

Non-Coding RNA Research
|January 6, 2025
PubMed

Insights

Circular RNAs (circRNAs) are emerging as key regulators in cardiac fibrosis, a common pathway in cardiovascular diseases (CVDs). Understanding these non-coding RNAs offers new potential for diagnosing and treating heart conditions.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • RNA Biology

Background:

  • Cardiovascular diseases (CVDs) are a leading global cause of mortality.
  • Cardiac fibrosis is a common pathological hallmark in the progression of most CVDs.
  • The exact mechanisms initiating cardiac fibrosis remain incompletely elucidated.

Purpose of the Study:

  • To provide a concise overview of current knowledge.
  • To highlight the regulatory roles of circular RNAs (circRNAs) in cardiac fibrosis.
  • To underscore the potential of circRNAs in CVDs.

Main Methods:

  • Literature review of recent investigations.
  • Synthesis of findings on circRNA functions.
  • Analysis of circRNA properties (abundance, stability, specificity).

Main Results:

  • Circular RNAs (circRNAs) are non-coding regulatory RNA molecules with diverse biological functions.
  • circRNAs demonstrate potential as biomarkers, therapeutic targets, and agents due to their stability and specificity.
  • Emerging research indicates significant involvement of circRNAs in the development of cardiac fibrosis.

Conclusions:

  • circRNAs play crucial regulatory roles in cardiac fibrosis.
  • Further research into circRNAs could lead to novel diagnostic and therapeutic strategies for CVDs.
  • The unique characteristics of circRNAs position them as promising candidates for future cardiovascular research.
Keywords:
BiomarkerCardiac fibrosisCircular RNAsTherapeutic agentTherapeutic target

More Related Videos

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

9.9K
Use of Alu Element Containing Minigenes to Analyze Circular RNAs13:10

Use of Alu Element Containing Minigenes to Analyze Circular RNAs

Published on: March 10, 2020

7.3K

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
3.6K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
841